Glucocorticoid-Induced Obesity Develops Independently of UCP1
Standard
Glucocorticoid-Induced Obesity Develops Independently of UCP1. / Luijten, Ineke H N; Brooks, Katie; Boulet, Nathalie; Shabalina, Irina G; Jaiprakash, Ankita; Carlsson, Bo; Fischer, Alexander W; Cannon, Barbara; Nedergaard, Jan.
In: CELL REP, Vol. 27, No. 6, 07.05.2019, p. 1686-1698.e5.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Glucocorticoid-Induced Obesity Develops Independently of UCP1
AU - Luijten, Ineke H N
AU - Brooks, Katie
AU - Boulet, Nathalie
AU - Shabalina, Irina G
AU - Jaiprakash, Ankita
AU - Carlsson, Bo
AU - Fischer, Alexander W
AU - Cannon, Barbara
AU - Nedergaard, Jan
N1 - Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
PY - 2019/5/7
Y1 - 2019/5/7
N2 - An excess of glucocorticoids leads to the development of obesity in both mice and humans, but the mechanism for this is unknown. Here, we determine the extent to which decreased BAT thermogenic capacity (as a result of glucocorticoid treatment) contributes to the development of obesity. Contrary to previous suggestions, we show that only in mice housed at thermoneutrality (30°C) does corticosterone treatment reduce total BAT UCP1 protein. This reduction is reflected in reduced brown adipocyte cellular and mitochondrial UCP1-dependent respiration. However, glucocorticoid-induced obesity develops to the same extent in animals housed at 21°C and 30°C, whereas total BAT UCP1 protein levels differ 100-fold between the two groups. In corticosterone-treated wild-type and UCP1 knockout mice housed at 30°C, obesity also develops to the same extent. Thus, our results demonstrate that the development of glucocorticoid-induced obesity is not caused by a decreased UCP1-dependent thermogenic capacity.
AB - An excess of glucocorticoids leads to the development of obesity in both mice and humans, but the mechanism for this is unknown. Here, we determine the extent to which decreased BAT thermogenic capacity (as a result of glucocorticoid treatment) contributes to the development of obesity. Contrary to previous suggestions, we show that only in mice housed at thermoneutrality (30°C) does corticosterone treatment reduce total BAT UCP1 protein. This reduction is reflected in reduced brown adipocyte cellular and mitochondrial UCP1-dependent respiration. However, glucocorticoid-induced obesity develops to the same extent in animals housed at 21°C and 30°C, whereas total BAT UCP1 protein levels differ 100-fold between the two groups. In corticosterone-treated wild-type and UCP1 knockout mice housed at 30°C, obesity also develops to the same extent. Thus, our results demonstrate that the development of glucocorticoid-induced obesity is not caused by a decreased UCP1-dependent thermogenic capacity.
KW - Adipose Tissue, Brown/metabolism
KW - Adiposity
KW - Animals
KW - Cell Respiration
KW - Corticosterone/adverse effects
KW - Down-Regulation
KW - Feeding Behavior
KW - Glucocorticoids/adverse effects
KW - Mice
KW - Mitochondria/metabolism
KW - Obesity/etiology
KW - Phenotype
KW - Temperature
KW - Transcription, Genetic
KW - Uncoupling Protein 1/metabolism
U2 - 10.1016/j.celrep.2019.04.041
DO - 10.1016/j.celrep.2019.04.041
M3 - SCORING: Journal article
C2 - 31067456
VL - 27
SP - 1686-1698.e5
JO - CELL REP
JF - CELL REP
SN - 2211-1247
IS - 6
ER -